41.13
[1]. B Bruguerolle, et al. Acute toxicity of bupivacaine metabolites in mice. Clin Exp Pharmacol Physiol. 1994 Dec;1(1):997-9.
[]. B Bruguerolle, et al. Bupivacaine kinetics during hyperthermia in rats. Can J Anaesth. 1994 Mar;41(3):53-6.
[3]. B Bruguerolle, et al. Kinetics of bupivacaine after clonidine pretreatment in mice. Can J Anaesth. 1995 May;4(5 Pt 1):434-7.
[4]. Einosuke Tanaka, et al. Effects of premedication medicines on the formation of the CYP3A4-dependent metabolite of ropivacaine, ', 6'-Pipecoloxylidide, on human liver microsomes in vitro. Basic Clin Pharmacol Toxicol. 006 Feb;98():181-3.
[5]. L Aarons, et al. Population pharmacokinetic analysis of ropivacaine and its metabolite ',6'-pipecoloxylidide from pooled data in neonates, infants, and children. Br J Anaesth. 011 Sep;107(3):409-4.
P64-P70-P330-P405-P501
811